Angiotensin Receptor Blockers: Do They Protect Against Dementia and Alzheimer’s Disease in the Elderly?

Tzvi Dwolatzky


Aging health. 2010;6(3):85-287. 

In This Article

Future Perspective

The role of angiotensin receptor blockers in preventing cognitive decline and the progression of dementia, including AD, is strengthened by this study. A well-designed randomized controlled study involving a heterogeneous population sample should follow, with emphasis placed on the definition of AD and dementia, as well as cognitive outcome measures. The possible mechanisms of action of angiotensin receptor blockers on cerebral function and neurobiology should be further elucidated.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.